Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
Why Merck's Latest Success Means Trouble for Exelixis Inc.
Yahoo/Motley Fool
Fri, 10/19/18 - 09:13 am
Merck
Exelixis
Cabometyx
Keytruda
Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer combination win
Fierce Pharma
Thu, 10/18/18 - 01:07 pm
Merck
Keytruda
kidney cancer
Pfizer
Inlyta
Sutent
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag
Fierce Pharma
Wed, 09/19/18 - 11:53 am
drug pricing
China
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Merck's Keytruda clocks up new win as EU approves chemo cocktail
Yahoo/Reuters
Mon, 09/10/18 - 09:38 am
Merck
Keytruda
Europe
advanced non-squamous non-small cell lung cancer
Merck's Keytruda threatens Pfizer, Merck KGaA's Bavencio with Merkel cell 'priority' tag
Fierce Pharma
Tue, 09/4/18 - 11:05 am
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
FDA
FDA gives Merck ‘real-time’ OK for Keytruda, offering a peek at the latest extension of the agency’s data express highway
Endpoints
Tue, 08/21/18 - 10:19 am
Keytruda
Merck
non-squamous non-small cell lung cancer
FDA
After an epic battle of blockbusters, Merck leapfrogs Bristol-Myers to take the lead on PD-1/L1 market
Endpoints
Sat, 07/28/18 - 01:02 pm
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
anti-PD-L1
Keytruda Becomes the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma
CP Wire
Thu, 07/26/18 - 11:47 am
Merck
Keytruda
melanoma
China
Keytruda Becomes the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma
Thu, 07/26/18 - 09:47 am
Merck
Keytruda
melanoma
Merck claims a needed win for Keytruda with interim OS data in head and neck cancer
Endpoints
Wed, 07/25/18 - 11:03 am
Merck
Keytruda
clinical trials
squamous cell carcinoma of the head and neck
Is Roche's latest Tecentriq win really a win for Merck's Keytruda?
Fierce Pharma
Thu, 07/19/18 - 11:14 am
Roche
immuno-oncology
Tecentriw
Merck
Keytruda
non-small cell lung cancer
FDA Limits the Use of Tecentriq and Keytruda
RAPS.org
Wed, 07/4/18 - 11:25 am
FDA
Roche
Merck
Tecentriq
Keytruda
metastatic urothelial cancer
FDA Grants Priority Review to Keytruda Combination Therapy for Metastatic Squamous Non-Small Cell Lung Cancer
CP Wire
Mon, 07/2/18 - 09:21 am
Merck
Keytruda
non-small cell lung cancer
metastatic squamous non-small cell lung cancer
priority review
FDA
FDA Grants Priority Review to Keytruda Combination Therapy for Metastatic Squamous Non-Small Cell Lung Cancer
Mon, 07/2/18 - 09:16 am
Merck
Keytruda
squamous cell non-small cell lung cancer
FDA limits first-line bladder cancer labels for Keytruda, Tecentriq
Biopharma Dive
Fri, 06/22/18 - 12:13 pm
FDA
Merck
Keytruda
Roche
Tecentriq
bladder cancer
Bristol-Myers clears another hurdle in Merck lung cancer showdown — but big challenges remain
Endpoints
Fri, 06/22/18 - 09:57 am
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Merck's Keytruda snags I-O's first cervical cancer nod to back up HPV fighter Gardasil
Fierce Pharma
Wed, 06/13/18 - 11:56 am
Merck
Keytruda
FDA
cervical cancer
AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024
Fierce Pharma
Fri, 06/8/18 - 09:48 am
Humira
AbbVie
Keytruda
Merck
Revlimid
Celgene
Opdivo
Bristol-Myers Squibb
ASCO18: 3 unanswered questions from oncology's largest conference
Biopharma Dive
Thu, 06/7/18 - 09:35 am
ASCO 2018
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
immunotherapy combinations
non-small cell lung cancer
ASCO: Merck and its new multibillion-dollar partners hone plans for marketing onslaught
Fierce Pharma
Mon, 06/4/18 - 12:09 pm
Merck
ASCO 2018
Keytruda
AstraZeneca
Eisai
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »